This performance was also supported by syringe demand and other containment. The division's gross margin decreased to 28% ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the third quarter of 2024, along with recent product highlights and corporate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback